Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | ALPL | P05186 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 3/20 | 0.31 |
| ▸ | GFER | P55789 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8660213 | 0.95 | CASP1 (0.39) | CASP1ALDH1A1LMNASMN1; SMN2MAPT | |
| SCHEMBL26109106 | 0.93 | ALDH1A1 (0.39) | CASP1ALDH1A1LMNASMN1; SMN2MAPT | |
| SCHEMBL26111987 | 0.93 | ALDH1A1 (0.39) | CASP1ALDH1A1LMNASMN1; SMN2MAPT | |
| SCHEMBL26106560 | 0.93 | ALDH1A1 (0.39) | CASP1ALDH1A1LMNASMN1; SMN2MAPT | |
| SCHEMBL26111776 | 0.93 | ALDH1A1 (0.39) | CASP1ALDH1A1LMNASMN1; SMN2MAPT | |
| SCHEMBL8658631 | 0.93 | ALDH1A1 (0.39) | CASP1ALDH1A1LMNASMN1; SMN2MAPT | |
| SCHEMBL26109650 | 0.93 | ALDH1A1 (0.39) | CASP1ALDH1A1LMNASMN1; SMN2MAPT | |
| SCHEMBL9830433 | 0.87 | SMN1; SMN2 (0.47) | CASP1ALDH1A1LMNASMN1; SMN2MAPT | |
| SCHEMBL20472373 | 0.87 | ALDH1A1 (0.50) | CASP1ALDH1A1LMNASMN1; SMN2MAPT | |
| SCHEMBL1957909 | 0.83 | ALDH1A1 (0.53) | ALDH1A1LMNASMN1; SMN2MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4722199-A1 | AZOLE COMPOUND, METHOD FOR SYNTHESIZING SAID AZOLE COMPOUND, AND USE THEREOF | SHIKOKU CHEMICALS CORPORATION (JP) | 2026-04-08 | — | — | EP | disclosed |
| US-20250215572-A1 | SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY | SHIKOKU CHEMICALS CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| US-20250206764-A1 | TRIAZOLE COMPOUND, METHOD FOR SYNTHESIZING SAID TRIAZOLE COMPOUND, COUPLING AGENT AND USES THEREOF | SHIKOKU CHEMICALS CORPORATION (JP) | 2025-06-26 | — | — | US | disclosed |
| EP-4506488-A1 | SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY | Shikoku Chemicals Corporation (JP) | 2025-02-12 | — | — | EP | disclosed |
| EP-4501937-A1 | TRIAZOLE COMPOUND, METHOD FOR SYNTHESIZING SAID TRIAZOLE COMPOUND, COUPLING AGENT AND USES THEREOF | Shikoku Chemicals Corporation (JP) | 2025-02-05 | — | — | EP | disclosed |
| WO-2024247919-A1 | AZOLE COMPOUND, METHOD FOR SYNTHESIZING SAID AZOLE COMPOUND, AND USE THEREOF | 四国化成工業株式会社 | 2024-12-05 | — | — | WO | disclosed |
| CN-118922427-A | Triazole compound, synthesis method of triazole compound, coupling agent and application thereof | 四国化成工业株式会社 | 2024-11-08 | — | — | CN | disclosed |
| CN-118922584-A | Surface treating agent for copper or copper alloy | 四国化成工业株式会社 | 2024-11-08 | — | — | CN | disclosed |
| WO-2024005117-A1 | SURFACE TREATMENT AGENT FOR METAL CORD AND USE OF SAID SURFACE TREATMENT AGENT | 四国化成工業株式会社 | 2024-01-04 | — | — | WO | disclosed |
| WO-2023190263-A1 | SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY | 四国化成工業株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023190264-A1 | TRIAZOLE COMPOUND, METHOD FOR SYNTHESIZING SAID TRIAZOLE COMPOUND, COUPLING AGENT AND USES THEREOF | 四国化成工業株式会社 | 2023-10-05 | — | — | WO | disclosed |
| EP-0872543-A2 | Corrosion-inhibiting cleaning composition | Henkel Kommanditgesellschaft auf Aktien (DE) | 1998-10-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250206764-A1 | TRIAZOLE COMPOUND, METHOD FOR SYNTHESIZING SAID TRIAZOLE COMPOUND, COUPLING AGENT AND USES THEREOF | CYP51A1, CYP3A5, NAT1 | CASP1 1676/4885ALDH1A1 812/4885LMNA 4731/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.